Repare Therapeutics Inc. (RPTX)
USD 0.97
(0.86%)
USD 0.97
(0.86%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | -80.07 Million USD | -61.47% |
| 2022 | 127.64 Million USD | 2899.2% |
| 2021 | 4.25 Million USD | 357.63% |
| 2020 | -1.65 Million USD | -70.66% |
| 2019 | -968 Thousand USD | -137.84% |
| 2018 | -407 Thousand USD | -299.02% |
| 2017 | -102 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 585 Thousand USD | -98.87% |
| 2024 Q1 | 51.9 Million USD | 313.87% |
| 2023 Q4 | 12.54 Million USD | 1029.82% |
| 2023 Q1 | 4.69 Million USD | -72.67% |
| 2023 Q2 | 29.19 Million USD | 521.76% |
| 2023 Q3 | 1.11 Million USD | -96.2% |
| 2023 FY | 49.18 Million USD | -61.47% |
| 2022 Q3 | 81.3 Million USD | 20893.61% |
| 2022 FY | 127.64 Million USD | 2899.2% |
| 2022 Q4 | 17.18 Million USD | -78.87% |
| 2022 Q2 | -391 Thousand USD | 98.5% |
| 2022 Q1 | -26.05 Million USD | -542.73% |
| 2021 FY | 4.25 Million USD | 357.63% |
| 2021 Q4 | 5.88 Million USD | 123.46% |
| 2021 Q3 | -25.08 Million USD | -25.88% |
| 2021 Q2 | -19.92 Million USD | -21.92% |
| 2021 Q1 | -16.34 Million USD | -49.03% |
| 2020 Q3 | -10.09 Million USD | -12.74% |
| 2020 Q1 | -8.63 Million USD | 57.43% |
| 2020 Q4 | -10.96 Million USD | -8.67% |
| 2020 FY | -1.65 Million USD | -70.66% |
| 2020 Q2 | -8.95 Million USD | -3.7% |
| 2019 Q2 | - USD | 0.0% |
| 2019 FY | -968 Thousand USD | -137.84% |
| 2019 Q4 | -20.27 Million USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2018 FY | -407 Thousand USD | -299.02% |
| 2017 FY | -102 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 105.275% |
| AlloVir, Inc. | -398 Thousand USD | -20018.09% |
| Aptorum Group Limited | -1.11 Million USD | -7083.176% |
| Ardelyx, Inc. | 106.66 Million USD | 175.07% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 133.261% |
| Bicycle Therapeutics plc | -129.52 Million USD | 38.179% |
| AbCellera Biologics Inc. | 38.02 Million USD | 310.572% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | 66825.0% |
| Chimerix, Inc. | 324 Thousand USD | 24812.963% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | -156.901% |
| Elevation Oncology, Inc. | -39 Thousand USD | -205207.692% |
| Alkermes plc | 1.37 Billion USD | 105.825% |
| Fortress Biotech, Inc. | 57.85 Million USD | 238.403% |
| Fortress Biotech, Inc. | 57.85 Million USD | 238.403% |
| Agenus Inc. | 139.61 Million USD | 157.351% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | 583.019% |
| Dyadic International, Inc. | 922.95 Thousand USD | 8775.377% |
| ImmuCell Corporation | 4.39 Million USD | 1921.311% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | 480.181% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 24.55% |
| Lantern Pharma Inc. | -174.84 Thousand USD | -45695.371% |
| Immix Biopharma, Inc. | -5468.00 USD | -1464237.966% |
| Incyte Corporation | 3.44 Billion USD | 102.327% |
| IO Biotech, Inc. | -756 Thousand USD | -10491.27% |
| Janux Therapeutics, Inc. | -46.83 Million USD | -70.947% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | -499.423% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | -181103.042% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 18.476% |
| Keros Therapeutics, Inc. | -664 Thousand USD | -11958.735% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | -145481.818% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | -1601300.0% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 166.863% |
| ContextLogic Inc. | 59 Million USD | 235.712% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | 10083.791% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | -15093.548% |
| MiMedx Group, Inc. | 266.84 Million USD | 130.006% |
| MEI Pharma, Inc. | 49.32 Million USD | 262.325% |
| Novavax, Inc. | 639.93 Million USD | 112.512% |
| NextCure, Inc. | -3.68 Million USD | -2073.453% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | 520.469% |
| Onconetix, Inc. | -1.12 Million USD | -7003.663% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | -176.408% |
| Opthea Limited | 21.72 Thousand USD | 368746.409% |
| Psyence Biomedical Ltd. | -240.00 USD | -33362400.0% |
| Vaxcyte, Inc. | -75 Million USD | -6.76% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | -139574.842% |
| Precigen, Inc. | 106 Thousand USD | 75637.736% |
| Pharming Group N.V. | 220.1 Million USD | 136.378% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | 15647.573% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | 8035.58% |
| PureTech Health plc | -1.6 Million USD | -4895.009% |
| Pyxis Oncology, Inc. | -2 Million USD | -3903.5% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 172.942% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 55.862% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | -15395.04% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | Infinity% |
| Seer, Inc. | 7.02 Million USD | 1239.462% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | -76.657% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | -264.17% |
| Acelyrin, Inc. | -115 Thousand USD | -69526.087% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | -796537.151% |
| SELLAS Life Sciences Group, Inc. | - USD | Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | -13922.767% |
| Senti Biosciences, Inc. | -2.68 Million USD | -2884.346% |
| Clearside Biomedical, Inc. | 7.87 Million USD | 1117.279% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | 2076.549% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | -1568.82% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | -1931.178% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | 374.881% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | 16243.145% |
| VYNE Therapeutics Inc. | 424 Thousand USD | 18984.434% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | -97546.341% |
| Wave Life Sciences Ltd. | 104.09 Million USD | 176.917% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 159.193% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 17.411% |
| ChromaDex Corporation | 50.78 Million USD | 257.68% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | 372.467% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | -34412.931% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | -16174.39% |
| Caribou Biosciences, Inc. | -77.59 Million USD | -3.186% |
| CRISPR Therapeutics AG | 240.95 Million USD | 133.23% |
| Precision BioSciences, Inc. | 40.47 Million USD | 297.84% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 18.432% |
| Innoviva, Inc. | 261.06 Million USD | 130.671% |
| Jaguar Health, Inc. | 7.72 Million USD | 1136.639% |
| Summit Therapeutics Inc. | -2.05 Million USD | -3805.854% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | 1928.917% |
| Aadi Bioscience, Inc. | 21.54 Million USD | 471.641% |
| ESSA Pharma Inc. | -118.49 Thousand USD | -67474.753% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | -55775.395% |
| GT Biopharma, Inc. | - USD | Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | 13247.783% |
| Akebia Therapeutics, Inc. | 120.47 Million USD | 166.462% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 125.527% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | 3210.723% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | -157704.493% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | -1028.064% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | -16773.005% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | -769803.846% |
| Soligenix, Inc. | 97.31 Thousand USD | 82382.579% |
| Century Therapeutics, Inc. | -10.8 Million USD | -640.772% |
| Kura Oncology, Inc. | -849 Thousand USD | -9331.095% |
| TScan Therapeutics, Inc. | -67.1 Million USD | -19.322% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | -54369.388% |
| Ocean Biomedical, Inc. | - USD | Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | 180.847% |
| Autolus Therapeutics plc | -4.86 Million USD | -1545.161% |
| Mineralys Therapeutics, Inc. | - USD | Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | 293.471% |
| Eterna Therapeutics Inc. | -168 Thousand USD | -47560.714% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | 184.531% |
| GRI Bio, Inc. | 10.84 Million USD | 838.585% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | 3252.38% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | -821.722% |
| IGM Biosciences, Inc. | -211.66 Million USD | 62.17% |
| INmune Bio, Inc. | 155 Thousand USD | 51758.065% |
| Heron Therapeutics, Inc. | 61.93 Million USD | 229.272% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5215.706% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -12247.83% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | -273419.164% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | 20017.91% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | -3911.523% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | -25481.47% |
| Coherus BioSciences, Inc. | 94.46 Million USD | 184.765% |
| Verastem, Inc. | -62 Thousand USD | -129045.161% |
| Abeona Therapeutics Inc. | 2.43 Million USD | 3388.296% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | -30578.161% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | 2745.193% |
| Histogen Inc. | 3.76 Million USD | 2224.436% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | 13996.723% |
| Surrozen, Inc. | -27.23 Million USD | -194.051% |
| Organovo Holdings, Inc. | -5.38 Million USD | -1385.804% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | -6545.475% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | -212.2% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | 499.312% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | -4043839.394% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | 1419.888% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | -119174.255% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 151.728% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | 55017.695% |
| Apollomics, Inc. | 127 Thousand USD | 63147.244% |
| Amarin Corporation plc | 165.54 Million USD | 148.369% |
| Mesoblast Limited | -9.81 Million USD | -715.792% |
| Turnstone Biologics Corp. | 16.5 Million USD | 585.096% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 27.531% |
| Synaptogenix, Inc. | -6347.00 USD | -1261440.885% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | -156900.0% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 149.62% |
| BriaCell Therapeutics Corp. | - USD | Infinity% |
| Monopar Therapeutics Inc. | - USD | Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 104.555% |
| Better Therapeutics, Inc. | -2.72 Million USD | -2834.042% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 28.612% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 123.684% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -701775.877% |
| Dermata Therapeutics, Inc. | - USD | Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | -1179.073% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7126.534% |
| TNF Pharmaceuticals, Inc. | - USD | Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | 1194.151% |
| Insmed Incorporated | 239.63 Million USD | 133.413% |
| Virpax Pharmaceuticals, Inc. | - USD | Infinity% |
| MediWound Ltd. | 3.57 Million USD | 2337.842% |
| OmniAb, Inc. | 14.66 Million USD | 645.919% |
| Alector, Inc. | -95.05 Million USD | 15.763% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 163.739% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | -84.226% |
| Zai Lab Limited | 170.9 Million USD | 146.851% |
| Revance Therapeutics, Inc. | 81.87 Million USD | 197.793% |
| Aura Biosciences, Inc. | -1.29 Million USD | -6083.012% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | 61692.308% |
| Immunic, Inc. | -111 Thousand USD | -72035.135% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | 605.046% |
| Veracyte, Inc. | 248.14 Million USD | 132.267% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 98.854% |
| FibroGen, Inc. | 128.9 Million USD | 162.116% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | -14196708.511% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | -586.301% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 102.356% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | 20683.548% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 122.533% |
| TG Therapeutics, Inc. | 219.1 Million USD | 136.544% |
| Galecto, Inc. | -830 Thousand USD | -9546.988% |
| Calithera Biosciences, Inc. | -1.38 Million USD | -5681.227% |
| Fortrea Holdings Inc. | 424 Million USD | 118.884% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 7.076% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | -14021.693% |
| XBiotech Inc. | -1.74 Million USD | -4491.17% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | -7126.534% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | -72.301% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | -6.005% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | 209.083% |
| Theravance Biopharma, Inc. | 16.8 Million USD | 576.522% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 120.581% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | -61.279% |
| Vaxxinity, Inc. | -2.23 Million USD | -3484.154% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 124.505% |
| Gain Therapeutics, Inc. | -11.32 Million USD | -607.092% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | 427.471% |
| NexImmune, Inc. | -1.02 Million USD | -7711.921% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | 1482877.778% |
| Marker Therapeutics, Inc. | -7.1 Million USD | -1026.849% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 100.708% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | -119716.84% |
| Scopus BioPharma Inc. | - USD | Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | -2154.858% |
| Ainos, Inc. | -253.73 Thousand USD | -31456.794% |
| Pluri Inc. | 322 Thousand USD | 24966.46% |
| Prothena Corporation plc | -129.2 Million USD | 38.027% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | 258.794% |
| Celularity Inc. | 6.75 Million USD | 1285.344% |
| Rallybio Corporation | -150 Thousand USD | -53280.0% |
| Cue Biopharma, Inc. | -32.6 Million USD | -145.561% |
| MeiraGTx Holdings plc | 287 Thousand USD | 27998.955% |
| Omeros Corporation | -69.77 Million USD | -14.748% |
| Humacyte, Inc. | -76.55 Million USD | -4.598% |
| Immunocore Holdings plc | 248.39 Million USD | 132.235% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | -427.853% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | 228.354% |
| Blueprint Medicines Corporation | 236.58 Million USD | 133.844% |
| CalciMedica, Inc. | -58 Thousand USD | -137951.724% |
| Cabaletta Bio, Inc. | -1.42 Million USD | -5515.007% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | 375.581% |
| Scholar Rock Holding Corporation | -2.84 Million USD | -2715.401% |
| Sana Biotechnology, Inc. | -30.86 Million USD | -159.42% |
| Pulmatrix, Inc. | -8.22 Million USD | -874.088% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | -6743.59% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | -19967.669% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 79.922% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | 2984.797% |
| Cytokinetics, Incorporated | -322.59 Million USD | 75.179% |
| Eloxx Pharmaceuticals, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 9387.732% |
| Protara Therapeutics, Inc. | -341 Thousand USD | -23380.938% |
| Vor Biopharma Inc. | -3.49 Million USD | -2192.955% |
| Roivant Sciences Ltd. | 109.23 Million USD | 173.301% |
| Evogene Ltd. | 1.39 Million USD | 5823.374% |
| ProKidney Corp. | -3.16 Million USD | -2426.665% |
| Applied Therapeutics, Inc. | -43.91 Million USD | -82.342% |
| Hoth Therapeutics, Inc. | - USD | Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | 1267.712% |
| CorMedix Inc. | -205.56 Thousand USD | -38851.752% |
| BioLineRx Ltd. | 1.1 Million USD | 7326.534% |
| Tango Therapeutics, Inc. | -78.67 Million USD | -1.778% |
| Galectin Therapeutics Inc. | -33 Thousand USD | -242536.364% |
| Atai Life Sciences N.V. | -5000.00 USD | -1601300.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | -65607.088% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | -83306.25% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | -5664.579% |
| Sagimet Biosciences Inc. | 2 Million USD | 4103.5% |
| MediciNova, Inc. | 979.7 Thousand USD | 8272.868% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 5.039% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -84580.874% |
| GeoVax Labs, Inc. | -20.72 Million USD | -286.424% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 132.744% |
| Biomea Fusion, Inc. | -4.2 Million USD | -1805.975% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 109.179% |
| Mereo BioPharma Group plc | 7.42 Million USD | 1178.239% |
| Cullinan Oncology, Inc. | -310 Thousand USD | -25729.032% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | -667150.0% |
| Absci Corporation | -41.84 Million USD | -91.331% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1601300.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | -4.841% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | -3153.555% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 137.462% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | -8409.033% |
| Allakos Inc. | -6.14 Million USD | -1203.859% |
| Imunon, Inc. | -720 Thousand USD | -11020.756% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | -16.05% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 116.825% |
| BioAtla, Inc. | -103.73 Million USD | 22.81% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | -701775.877% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | -44883.146% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 67.025% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | -25645.981% |
| XOMA Corporation | 3.86 Million USD | 2173.815% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | -14.247% |
| Cara Therapeutics, Inc. | 14.79 Million USD | 641.233% |
| aTyr Pharma, Inc. | -2.38 Million USD | -3253.015% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | 742.616% |
| Akero Therapeutics, Inc. | -29 Thousand USD | -276003.448% |
| Viridian Therapeutics, Inc. | -1 Million USD | -7843.452% |
| Eliem Therapeutics, Inc. | - USD | Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | 615923176.923% |
| Akari Therapeutics, Plc | -4000.00 USD | -2001650.0% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 112.572% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 41223.118% |
| UroGen Pharma Ltd. | 73.35 Million USD | 209.159% |
| Sutro Biopharma, Inc. | -26.69 Million USD | -199.955% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | 689764.083% |
| Orgenesis Inc. | -5.72 Million USD | -1298.603% |
| Entera Bio Ltd. | -56 Thousand USD | -142882.143% |
| GH Research PLC | -315 Thousand USD | -25319.048% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | -42265.079% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | -15151.429% |
| Xencor, Inc. | -85.26 Million USD | 6.087% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | -36134.54% |
| Replimune Group, Inc. | -2.65 Million USD | -2915.819% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | -7897.116% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 145.023% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | 41223.118% |
| Portage Biotech Inc. | -54 Thousand USD | -148177.778% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | -84580.874% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | -21138.727% |
| OncoCyte Corporation | 413 Thousand USD | 19487.409% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | -1781212.57% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | -36067467.568% |
| Purple Biotech Ltd. | -196 Thousand USD | -40752.041% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | 992.841% |
| scPharmaceuticals Inc. | 9.78 Million USD | 918.544% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | -666.59% |
| HilleVax, Inc. | -2.15 Million USD | -3613.822% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | -82446.392% |
| Tharimmune, Inc. | - USD | Infinity% |
| Genprex, Inc. | -15 Thousand USD | -533557.691% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | -11886.527% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | -348030.435% |
| XTL Biopharmaceuticals Ltd. | - USD | Infinity% |
| Virios Therapeutics, Inc. | - USD | Infinity% |
| OKYO Pharma Limited | -7506.16 USD | -1066623.864% |
| Savara Inc. | -44.26 Million USD | -80.9% |
| Curis, Inc. | 9.81 Million USD | 916.125% |
| Daré Bioscience, Inc. | 2.76 Million USD | 2991.113% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | -64064.824% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | -4531.001% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | -35018.421% |
| BeiGene, Ltd. | 2.07 Billion USD | 103.852% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | -2763.836% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 79.966% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | 241.247% |
| Erasca, Inc. | -3.73 Million USD | -2045.498% |
| bluebird bio, Inc. | -4.03 Million USD | -1886.849% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -283655.05% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 104.205% |
| DBV Technologies S.A. | 15.72 Million USD | 609.092% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | -283655.05% |
| Moderna, Inc. | 2.15 Billion USD | 103.716% |
| Vincerx Pharma, Inc. | -915 Thousand USD | -8650.82% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | 1100.125% |
| Molecular Templates, Inc. | 50.39 Million USD | 258.885% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | -14838.433% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 159.848% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | -1186.885% |
| Spruce Biosciences, Inc. | -39.34 Million USD | -103.518% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 27.948% |
| Cogent Biosciences, Inc. | -3.58 Million USD | -2131.605% |
| MacroGenics, Inc. | 50.52 Million USD | 258.47% |
| RenovoRx, Inc. | - USD | Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | -1213.053% |
| Prime Medicine, Inc. | -147.9 Million USD | 45.864% |
| Aditxt, Inc. | -111.66 Thousand USD | -71608.759% |
| Adagene Inc. | 18.11 Million USD | 542.095% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | 16507.787% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 157.11% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 150.73% |
| SciSparc Ltd. | 2.19 Million USD | 3746.175% |
| Vericel Corporation | 135.57 Million USD | 159.059% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -319553.479% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | -258340.385% |
| Generation Bio Co. | -73.91 Million USD | -8.333% |
| Astria Therapeutics, Inc. | - USD | Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | -18222.654% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | 246.597% |
| Invivyd, Inc. | -2.02 Million USD | -3848.225% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 73.385% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | -77308.689% |
| Spero Therapeutics, Inc. | 96.36 Million USD | 183.088% |
| Artelo Biosciences, Inc. | - USD | Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | 181.465% |
| ADMA Biologics, Inc. | 88.21 Million USD | 190.764% |
| Clene Inc. | 533 Thousand USD | 15122.514% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | 432.114% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | -8266.771% |
| GeoVax Labs, Inc. | -20.72 Million USD | -286.424% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | 4127.666% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | -41106.077% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | 260.767% |
| Relmada Therapeutics, Inc. | - USD | Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | -1029.019% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | -9477.751% |
| Vir Biotechnology, Inc. | 83.41 Million USD | 195.99% |
| Evaxion Biotech A/S | 73.11 Thousand USD | 109616.906% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | 250.615% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 53.767% |
| Trevena, Inc. | 1.45 Million USD | 5603.093% |
| Surrozen, Inc. | -27.23 Million USD | -194.051% |
| Tyra Biosciences, Inc. | -353 Thousand USD | -22582.72% |
| Cingulate Inc. | -582.91 Thousand USD | -13636.066% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | -258190.323% |
| Unity Biotechnology, Inc. | -19.69 Million USD | -306.467% |
| Tenax Therapeutics, Inc. | -7570.00 USD | -1057627.873% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | -8988.536% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 111.763% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | -8004.251% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | -142014.231% |
| Kronos Bio, Inc. | 1.37 Million USD | 5936.006% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | -49.201% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | -27321.233% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | -16297.236% |
| ImmunityBio, Inc. | -17.89 Million USD | -347.568% |
| Korro Bio, Inc. | -3.63 Million USD | -2105.785% |
| Kineta, Inc. | 5.43 Million USD | 1573.771% |
| BioVie Inc. | -229.37 Thousand USD | -34807.598% |
| Codexis, Inc. | 57.33 Million USD | 239.655% |
| Celularity Inc. | 6.75 Million USD | 1285.344% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | 2095.265% |
| Celcuity Inc. | -142.77 Thousand USD | -55982.425% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | 158372.386% |
| Cibus, Inc. | 1.42 Million USD | 5730.802% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | -21309.091% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | -249.361% |
| IN8bio, Inc. | -2.5 Million USD | -3101.519% |
| Kodiak Sciences Inc. | -25.94 Million USD | -208.591% |
| Annexon, Inc. | -3.26 Million USD | -2350.872% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | -3817.319% |
| Assembly Biosciences, Inc. | -41.73 Million USD | -91.844% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | 12610.938% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 110.285% |
| Eyenovia, Inc. | - USD | Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 146.295% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | -4114.211% |
| Arcellx, Inc. | 108.27 Million USD | 173.948% |
| Cardiff Oncology, Inc. | -32.36 Million USD | -147.366% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | 201.093% |
| Regulus Therapeutics Inc. | -21.15 Million USD | -278.546% |
| Moolec Science SA | -143.3 Thousand USD | -55773.836% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | -89.21% |
| Geron Corporation | -123.5 Million USD | 35.168% |
| LAVA Therapeutics N.V. | 3.28 Million USD | 2535.96% |
| Royalty Pharma plc | 1.79 Billion USD | 104.463% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | -14.239% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | -2216677.409% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | 34703.766% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 28.133% |
| Humacyte, Inc. | -76.55 Million USD | -4.598% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | -8335.756% |
| 89bio, Inc. | -273 Thousand USD | -29229.67% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | -6269.928% |
| Avenue Therapeutics, Inc. | - USD | Infinity% |
| Genelux Corporation | -848 Thousand USD | -9342.217% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | -64997.561% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | 7255.496% |
| Notable Labs, Ltd. | 113 Thousand USD | 70958.407% |
| Liquidia Corporation | 14.6 Million USD | 648.425% |
| Mustang Bio, Inc. | -2.22 Million USD | -3498.652% |
| Immunovant, Inc. | -231 Thousand USD | -34562.338% |
| Quantum-Si incorporated | 488 Thousand USD | 16507.787% |
| Arbutus Biopharma Corporation | -55.55 Million USD | -44.117% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | -266800.0% |
| Vera Therapeutics, Inc. | 1.86 Million USD | 4400.215% |
| Acasti Pharma Inc. | -11 Thousand USD | -727809.091% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | -39031.646% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | -12247.83% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 52.2% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | 7157.237% |
| NeuroBo Pharmaceuticals, Inc. | - USD | Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | -20915.748% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | -3989.377% |
| PepGen Inc. | -1.18 Million USD | -6662.669% |
| Moleculin Biotech, Inc. | -127 Thousand USD | -62947.244% |
| United Therapeutics Corporation | 2.07 Billion USD | 103.868% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -249.696% |
| Solid Biosciences Inc. | -76.56 Million USD | -4.581% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | -96857.001% |
| Immuneering Corporation | -764.13 Thousand USD | -10378.474% |
| Lixte Biotechnology Holdings, Inc. | - USD | Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | 120934.842% |
| Belite Bio, Inc | -399 Thousand USD | -19967.669% |
| XOMA Corporation | 3.86 Million USD | 2173.815% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | -299.631% |
| Bionomics Limited | -434.44 Thousand USD | -18330.242% |
| Apogee Therapeutics, Inc. | - USD | Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7355.307% |
| uniQure N.V. | 2.21 Million USD | 3714.898% |
| Cassava Sciences, Inc. | -89.42 Million USD | 10.459% |
| Estrella Immunopharma, Inc. | - USD | Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 13.033% |
| Forte Biosciences, Inc. | -9000.00 USD | -889566.667% |
| Anebulo Pharmaceuticals, Inc. | - USD | Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | -9489.222% |
| Conduit Pharmaceuticals Inc. | - USD | Infinity% |
| SeaStar Medical Holding Corporation | - USD | Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | -18222.654% |
| Altimmune, Inc. | -65.37 Million USD | -22.482% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 122.117% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | -7355.307% |
| Compugen Ltd. | 31.45 Million USD | 354.554% |
| Peak Bio, Inc. | 367.76 Thousand USD | 21871.819% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | 426.603% |
| Benitec Biopharma Inc. | 108 Thousand USD | 74238.889% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | -102553.846% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | -6555.86% |
| Zura Bio Limited | - USD | Infinity% |
| PolyPid Ltd. | -1.82 Million USD | -4294.621% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | -67185.714% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | -6555.86% |
| Instil Bio, Inc. | -4.75 Million USD | -1583.558% |
| argenx SE | 1.1 Billion USD | 107.223% |
| Immunome, Inc. | -8.9 Million USD | -798.956% |
| Compass Therapeutics, Inc. | -1.89 Million USD | -4136.508% |
| Verona Pharma plc | -679.62 Thousand USD | -11681.514% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | -45654.286% |
| Shattuck Labs, Inc. | -2.38 Million USD | -3257.233% |
| CervoMed Inc. | -1.29 Million USD | -6089.574% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | -3226.548% |
| Plus Therapeutics, Inc. | -4.77 Million USD | -1576.157% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | 3340.389% |
| Moolec Science SA | -143.3 Thousand USD | -55773.836% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | -19523.557% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | -2897.161% |
| AnaptysBio, Inc. | 14.78 Million USD | 641.709% |
| Design Therapeutics, Inc. | -537 Thousand USD | -14810.615% |
| Leap Therapeutics, Inc. | -427 Thousand USD | -18651.756% |
| NeurAxis, Inc. | 2.15 Million USD | 3812.61% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | 3831.128% |
| Lumos Pharma, Inc. | 2 Million USD | 4089.537% |
| Achilles Therapeutics plc | -4.73 Million USD | -1592.359% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | -45654.286% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | -75670.05% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | 352.916% |
| CERo Therapeutics Holdings, Inc. | - USD | Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | 9387.732% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | -7658.721% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | -75.793% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | 186309.302% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | -9640.876% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | -608427.132% |
| Palisade Bio, Inc. | 246 Thousand USD | 32648.78% |
| Tourmaline Bio, Inc. | -33 Thousand USD | -242536.364% |
| Beam Therapeutics Inc. | -59.67 Million USD | -34.184% |
| Neurogene Inc. | -3.26 Million USD | -2354.629% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 157.466% |
| AEON Biopharma, Inc. | - USD | Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | -2068.743% |
| Sesen Bio, Inc. | 40 Million USD | 300.175% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | -26859.596% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | -1888.311% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | -737.027% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | 668.679% |
| Athira Pharma, Inc. | -969 Thousand USD | -8163.158% |
| Vaccinex, Inc. | -16 Million USD | -400.312% |
| HCW Biologics Inc. | -574.82 Thousand USD | -13829.481% |
| XOMA Corporation | 3.86 Million USD | 2173.815% |
| Nektar Therapeutics | 53.47 Million USD | 249.725% |
| Arvinas, Inc. | 71.8 Million USD | 211.518% |
| Tevogen Bio Holdings Inc. | - USD | Infinity% |
| Merus N.V. | -83.46 Million USD | 4.063% |
| Omega Therapeutics, Inc. | -62.77 Million USD | -27.551% |
| Quince Therapeutics, Inc. | -322 Thousand USD | -24766.46% |
| Rezolute, Inc. | -36 Thousand USD | -222316.667% |
| Clene Inc. | 533 Thousand USD | 15122.514% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | -6235881.308% |
| BeyondSpring Inc. | 1.75 Million USD | 4672.816% |
| Synlogic, Inc. | -1.92 Million USD | -4061.642% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | -216305.405% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | -1164.529% |
| Peak Bio, Inc. | 367.76 Thousand USD | 21871.819% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | -322.243% |
| Krystal Biotech, Inc. | 47.6 Million USD | 268.197% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 156.751% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | 1693.433% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | -2992.438% |
| MannKind Corporation | 136.19 Million USD | 158.792% |
| Ikena Oncology, Inc. | -50.49 Million USD | -58.58% |
| Cyclerion Therapeutics, Inc. | - USD | Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 173.584% |
| Gossamer Bio, Inc. | -4.38 Million USD | -1725.998% |
| CohBar, Inc. | - USD | Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | -31673.81% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | -1601300.0% |
| Legend Biotech Corporation | 140.92 Million USD | 156.816% |
| Mural Oncology plc | -2.56 Million USD | -3019.205% |
| Biora Therapeutics, Inc. | -551 Thousand USD | -14431.76% |
| PaxMedica, Inc. Common Stock | - USD | Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | -79970.0% |
| Champions Oncology, Inc. | 20.75 Million USD | 485.805% |
| REGENXBIO Inc. | 53.02 Million USD | 250.993% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | -1394.693% |
| Anavex Life Sciences Corp. | - USD | Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | -41521.832% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | -4522.979% |
| Vaxart, Inc. | -60.76 Million USD | -31.774% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | -30370.355% |
| Cellectis S.A. | 18 Thousand USD | 444933.333% |
| Longeveron Inc. | 221 Thousand USD | 36330.769% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 107.326% |
| Inozyme Pharma, Inc. | -1.29 Million USD | -6087.79% |
| Revolution Medicines, Inc. | -399.66 Million USD | 79.966% |
| Nymox Pharmaceutical Corporation | - USD | Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | -228671.429% |
| ArriVent BioPharma, Inc. Common Stock | - USD | Infinity% |
| AN2 Therapeutics, Inc. | - USD | Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | 163508.163% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 100.93% |
| Denali Therapeutics Inc. | -93.34 Million USD | 14.221% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | -319553.479% |
| Veru Inc. | 7.56 Million USD | 1158.297% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | -52926.49% |
| Cingulate Inc. | -582.91 Thousand USD | -13636.066% |
| Passage Bio, Inc. | -3.72 Million USD | -2051.841% |
| Context Therapeutics Inc. | -12.04 Thousand USD | -664712.355% |
| Exicure, Inc. | -1.42 Million USD | -5526.845% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | -20806.005% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | 3062.264% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | -15518.082% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | 217.532% |
| Nuvalent, Inc. | - USD | Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | -53420.223% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | -35.24% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | 20578.261% |
| OmniAb, Inc. | 14.66 Million USD | 645.919% |
| Anew Medical, Inc. | - USD | Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | 500.49% |
| Lipocine Inc. | -2.85 Million USD | -2708.668% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | -4244.547% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | -1303.506% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | -5215.706% |
| G1 Therapeutics, Inc. | 75.31 Million USD | 206.312% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | -123084.615% |
| Sage Therapeutics, Inc. | 84.29 Million USD | 194.987% |
| Ocugen, Inc. | -33.53 Million USD | -138.751% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | -2432.258% |
| Q32 Bio Inc. | 578 Thousand USD | 13952.941% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | -30115.094% |
| Alumis Inc. Common Stock | -1.28 Million USD | -6135.981% |
| Equillium, Inc. | 35.95 Million USD | 322.676% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | -4590.685% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | 16092.282% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | -1936765.022% |
| Galera Therapeutics, Inc. | -259 Thousand USD | -30815.058% |
| Evelo Biosciences, Inc. | - USD | Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | 19041.975% |
| Dominari Holdings Inc. | 2.03 Million USD | 4026.925% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | -43541.774% |
| vTv Therapeutics Inc. | -13.59 Million USD | -488.967% |
| Bio-Techne Corporation | 773.07 Million USD | 110.357% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | 562.325% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 117.377% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | -6749.444% |
| Candel Therapeutics, Inc. | -23.98 Million USD | -233.903% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | 784.534% |
| Nkarta, Inc. | -5.86 Million USD | -1264.287% |
| BioCardia, Inc. | -7.24 Million USD | -1004.566% |
| Iterum Therapeutics plc | -1.75 Million USD | -4475.429% |